UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Modifiers of Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Systematic Review and Meta-Analysis

JNCI : Journal of the National Cancer Institute, 2014-06, Vol.106 (6), p.dju091-dju091

2014

Volltextzugriff (PDF)

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility

Journal of clinical oncology, 2015-11, Vol.33 (31), p.3660-3667

2015

Volltextzugriff (PDF)

Update on Genetic Testing in Gynecologic Cancer

Journal of clinical oncology, 2019-09, Vol.37 (27), p.2501-2509

2019

Volltextzugriff (PDF)

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2

PLoS genetics, 2018-12, Vol.14 (12), p.e1007752-e1007752

2018

Volltextzugriff (PDF)

Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer

American journal of human genetics, 2016-05, Vol.98 (5), p.801-817

2016

Volltextzugriff (PDF)

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

The Lancet (British edition), 2010-07, Vol.376 (9737), p.235-244

2010

Volltextzugriff (PDF)

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers

Nature communications, 2017-08, Vol.8 (1), p.319-11, Article 319

2017

Volltextzugriff (PDF)

Genomic Signatures Predict the Immunogenicity of BRCA-Deficient Breast Cancer

Clinical cancer research, 2019-07, Vol.25 (14), p.4363-4374

2019

Volltextzugriff (PDF)

Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction

Journal of the American Heart Association, 2020-01, Vol.9 (2), p.e014708

2020

Volltextzugriff (PDF)

Cancer treatment according to BRCA1 and BRCA2 mutations

Nature reviews. Clinical oncology, 2012-09, Vol.9 (9), p.520-528

2012

Volltextzugriff (PDF)

Identification of BRCA1/2 mutation female carriers using circulating microRNA profiles

Nature communications, 2023-06, Vol.14 (1), p.3350-3350, Article 3350

2023

Volltextzugriff (PDF)

Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: A Multicenter, Prospective Study

Journal of clinical oncology, 2008-03, Vol.26 (8), p.1331-1337

2008

Volltextzugriff (PDF)

Relationship of established risk factors with breast cancer subtypes

Cancer medicine (Malden, MA), 2021-09, Vol.10 (18), p.6456-6467

2021

Volltextzugriff (PDF)

Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study

Radiology, 2007-08, Vol.244 (2), p.381-388

2007

Volltextzugriff (PDF)

Risk-Reducing Mastectomy in BRCA1 and BRCA2 Mutation Carriers: A Complex Discussion

JAMA : the journal of the American Medical Association, 2019-01, Vol.321 (1), p.27

Domchek, Susan M.

2019

Volltextzugriff (PDF)

Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers

Nature communications, 2022-11, Vol.13 (1), p.6728-19, Article 6728

2022

Volltextzugriff (PDF)

Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinoma

Cancer, 2003-06, Vol.97 (12), p.2972-2977

2003

Volltextzugriff (PDF)

Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma

Nature medicine, 2011-08, Vol.17 (8), p.941-943

2011

Volltextzugriff (PDF)

Immunotherapy for Breast Cancer: What Are We Missing?

Clinical cancer research, 2017-06, Vol.23 (11), p.2640-2646

2017

Volltextzugriff (PDF)

The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk

NPJ breast cancer, 2017-06, Vol.3 (1), p.22-10, Article 22

2017

Volltextzugriff (PDF)

Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study

The lancet oncology, 2006-03, Vol.7 (3), p.223-229

2006

Volltextzugriff (PDF)

Reversion Mutations with Clinical Use of PARP Inhibitors: Many Genes, Many Versions

Cancer discovery, 2017-09, Vol.7 (9), p.937-939

Domchek, Susan M

2017

Volltextzugriff (PDF)

Risk of metachronous breast cancer after BRCA mutation–associated ovarian cancer

Cancer, 2013-04, Vol.119 (7), p.1344-1348

2013

Volltextzugriff (PDF)

Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers

Breast cancer research and treatment, 2014-11, Vol.148 (2), p.397-406

2014

Volltextzugriff (PDF)

1 – 25 von 445

Suche als RSS-Feed

Aktive Filter

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(432)
Mit Volltextzugriff
(367)

Publikationsform

Artikel
(443)
Buchkapitel
(2)

Sprache

Japanisch
(38)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Modifiers of Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Systematic Review and Meta-Analysis

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility

Update on Genetic Testing in Gynecologic Cancer

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2

Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers

Genomic Signatures Predict the Immunogenicity of BRCA-Deficient Breast Cancer

Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction

Cancer treatment according to BRCA1 and BRCA2 mutations

Identification of BRCA1/2 mutation female carriers using circulating microRNA profiles

Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: A Multicenter, Prospective Study

Relationship of established risk factors with breast cancer subtypes

Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study

Risk-Reducing Mastectomy in BRCA1 and BRCA2 Mutation Carriers: A Complex Discussion

Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers

Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinoma

Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma

Immunotherapy for Breast Cancer: What Are We Missing?

The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk

Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study

Reversion Mutations with Clinical Use of PARP Inhibitors: Many Genes, Many Versions

Risk of metachronous breast cancer after BRCA mutation–associated ovarian cancer

Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers

Protocol to evaluate sequential electronic health record-based strategies to increase genetic testing for breast and ovarian cancer risk across diverse patient populations in gynecology practices

Aktive Filter

Suchergebnisse filtern